Parexel International Corp - Company Profile
Powered by 
All the sales intelligence you need on Parexel International Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Parexel International Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Parexel International Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Parexel International Corp’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 26 Oct 2023 | Transcenta Holding Ltd Enters Phase III Clinical Trial Agreement with Parexel International Corp for osemitamab (GDCT0476185) | Contract Service Agreement |
Transcenta Holding Ltd
|
Parexel International Corp |
| 19 Sep 2023 | PMV Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with Parexel International Corp for PC-14586 (GDCT0499169) | Contract Service Agreement |
PMV Pharmaceuticals Inc
|
Parexel International Corp |
| 01 Aug 2023 | Guangzhou Zhiyi Biotechnology Co Ltd Enters Phase I Clinical Trial Agreement with Parexel International Corp for SK-10 (GDCT0469770) | Contract Service Agreement |
Guangzhou Zhiyi Biotechnology Co Ltd
|
Parexel International Corp |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer